Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)

NCT07057089 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: Capecitabine
DRUG: Camrelizumab
DRUG: CAPOX
RADIATION: Involve-field irradiation
RADIATION: Elective nodal irradiation
PROCEDURE: TME surgery

Sponsor

Hebei Medical University Fourth Hospital